Hematology/Oncology

Top Story

Delaying colonoscopy after positive FIT linked to higher CRC risk

Delaying colonoscopy after positive FIT linked to higher CRC risk
April 25, 2017

Patients with a positive fecal immunochemical test who waited more than 10 months to undergo the required follow-up colonoscopy had a higher risk for colorectal cancer and a more advanced stage of disease at diagnosis compared with patients who underwent follow-up colonoscopy within a month, according to new research published in JAMA.

However, given the observational nature of the study, “further research is needed to assess whether this relationship is causal,” Douglas A. Corley, MD, PhD, of the division of research at Kaiser Permanente Northern California, and colleagues wrote.

FDA News

FDA issues warnings about fraudulent cancer treatments

April 25, 2017
The FDA issued warning letters to 14 U.S. companies that the agency contends are selling products fraudulently claimed to prevent, diagnose, treat or cure cancer. The…
In the Journals Plus

Blinatumomab shows promise for subset of relapsed, refractory ALL

April 25, 2017
Single-agent blinatumomab demonstrated activity in high-risk patients with Philadelphia chromosome–positive B-cell precursor acute lymphoblastic leukemia…

Penn professor to become American Academy of Orthopedic Surgeons’ first female president

April 25, 2017
Kristy L. Weber, MD, will become the first female president of the American Academy of Orthopedic Surgeons in 2019. Weber, chief of orthopedic oncology for University…
In the Journals Plus

Collection of patient-reported symptoms, adverse events ‘highly feasible’ during clinical trials

April 24, 2017
Patient reports of their own symptomatic adverse events during multicenter clinical cancer trials proved possible and led to improved efficacy and safety monitoring in…
More News Headlines »
CME

Immune Checkpoint Inhibition for Melanoma Management: When, What, How, and in Whom?

This activity is supported by educational grants from Bristol-Myers Squibb and Merck & Co., Inc.

It is estimated that 76,380 new cases of melanoma will be diagnosed in the United Stated in 2017, with approximately…
More »
Video
Meeting News

VIDEO: Molecular alterations may identify intermediate stages of melanoma progression

April 8, 2017
More »
Featured
American Association for Cancer Research Annual Meeting

American Association for Cancer Research Annual Meeting

CME

Hot Topics in Metastatic Breast Cancer Management: Clinical Advances with CDK4/6 Inhibitors

This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.

While the mortality rates for advanced or metastatic breast cancer (MBC) have steadily decreased, in part due to…
More »
Current Issues
View the Current Issue
HemOnc Today
Advertisement
Advertisement